Optimal composition of intravenous lipids
The provision of energy from a lipid source is an essential component of any parenteral nutrition (PN) therapeutic regimen in the appropriate clinical setting. All available sources of intravenous lipid emulsions have a low osmolarity but they strongly differ in their immunologic effects and their e...
Gespeichert in:
| Veröffentlicht in: | The South African journal of clinical nutrition 2010-01, Vol.23 (sup1), p.11-14 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 14 |
|---|---|
| container_issue | sup1 |
| container_start_page | 11 |
| container_title | The South African journal of clinical nutrition |
| container_volume | 23 |
| creator | Kreymann, G. |
| description | The provision of energy from a lipid source is an essential component of any parenteral nutrition (PN) therapeutic regimen in the appropriate clinical setting. All available sources of intravenous lipid emulsions have a low osmolarity but they strongly differ in their immunologic effects and their effects on oxidative stress, liver injury and mitochondrial function. The ω−9/ω−6 lipid emulsion with its relative immune-neutrality and also the newer fish oil admixtures are lipid emulsions that can be used in most critically ill and non-critically ill patients. Despite extensive research and encouraging progress in the availability of such lipid emulsions, there is still need for a lipid emulsions that could be advantageous in patients with real hyperinflammation. |
| doi_str_mv | 10.1080/16070658.2010.11734261 |
| format | Article |
| fullrecord | <record><control><sourceid>crossref_infor</sourceid><recordid>TN_cdi_crossref_primary_10_1080_16070658_2010_11734261</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1080_16070658_2010_11734261</sourcerecordid><originalsourceid>FETCH-LOGICAL-c260t-76a14c4e16e17a585e359be096aa94938a765bef818b2b6644125cb3344ac5443</originalsourceid><addsrcrecordid>eNqFj01LAzEYhIMoWKt_QfbqYWvefO-xFL-g0Iuew7tpApHdzZKsSv-9XWrPngaGmWEeQu6BroAa-giKaqqkWTE6W6C5YAouyIIxBjUwZS7JYg7Vc-qa3JTySangWooFediNU-yxq1zqx1TiFNNQpVDFYcr47Yf0VaoujnFfbslVwK74uz9dko_np_fNa73dvbxt1tvaMUWnWisE4YQH5UGjNNJz2bSeNgqxEQ03qJVsfTBgWtYqJQQw6VrOhUAnheBLok67LqdSsg92zMeH-WCB2hnYnoHtDGzPwMfi-lSMQ0i5x5-Uu72d8NClHDIOLhbL_9n4BaYlW9A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Optimal composition of intravenous lipids</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>African Journals Online (Open Access)</source><source>Sabinet African Journals Open Access Collection</source><creator>Kreymann, G.</creator><creatorcontrib>Kreymann, G.</creatorcontrib><description>The provision of energy from a lipid source is an essential component of any parenteral nutrition (PN) therapeutic regimen in the appropriate clinical setting. All available sources of intravenous lipid emulsions have a low osmolarity but they strongly differ in their immunologic effects and their effects on oxidative stress, liver injury and mitochondrial function. The ω−9/ω−6 lipid emulsion with its relative immune-neutrality and also the newer fish oil admixtures are lipid emulsions that can be used in most critically ill and non-critically ill patients. Despite extensive research and encouraging progress in the availability of such lipid emulsions, there is still need for a lipid emulsions that could be advantageous in patients with real hyperinflammation.</description><identifier>ISSN: 1607-0658</identifier><identifier>EISSN: 2221-1268</identifier><identifier>DOI: 10.1080/16070658.2010.11734261</identifier><language>eng</language><publisher>Taylor & Francis</publisher><ispartof>The South African journal of clinical nutrition, 2010-01, Vol.23 (sup1), p.11-14</ispartof><rights>Copyright 2010 Taylor and Francis Group LLC 2010</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c260t-76a14c4e16e17a585e359be096aa94938a765bef818b2b6644125cb3344ac5443</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,782,786,27931,27932</link.rule.ids></links><search><creatorcontrib>Kreymann, G.</creatorcontrib><title>Optimal composition of intravenous lipids</title><title>The South African journal of clinical nutrition</title><description>The provision of energy from a lipid source is an essential component of any parenteral nutrition (PN) therapeutic regimen in the appropriate clinical setting. All available sources of intravenous lipid emulsions have a low osmolarity but they strongly differ in their immunologic effects and their effects on oxidative stress, liver injury and mitochondrial function. The ω−9/ω−6 lipid emulsion with its relative immune-neutrality and also the newer fish oil admixtures are lipid emulsions that can be used in most critically ill and non-critically ill patients. Despite extensive research and encouraging progress in the availability of such lipid emulsions, there is still need for a lipid emulsions that could be advantageous in patients with real hyperinflammation.</description><issn>1607-0658</issn><issn>2221-1268</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><recordid>eNqFj01LAzEYhIMoWKt_QfbqYWvefO-xFL-g0Iuew7tpApHdzZKsSv-9XWrPngaGmWEeQu6BroAa-giKaqqkWTE6W6C5YAouyIIxBjUwZS7JYg7Vc-qa3JTySangWooFediNU-yxq1zqx1TiFNNQpVDFYcr47Yf0VaoujnFfbslVwK74uz9dko_np_fNa73dvbxt1tvaMUWnWisE4YQH5UGjNNJz2bSeNgqxEQ03qJVsfTBgWtYqJQQw6VrOhUAnheBLok67LqdSsg92zMeH-WCB2hnYnoHtDGzPwMfi-lSMQ0i5x5-Uu72d8NClHDIOLhbL_9n4BaYlW9A</recordid><startdate>20100101</startdate><enddate>20100101</enddate><creator>Kreymann, G.</creator><general>Taylor & Francis</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20100101</creationdate><title>Optimal composition of intravenous lipids</title><author>Kreymann, G.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c260t-76a14c4e16e17a585e359be096aa94938a765bef818b2b6644125cb3344ac5443</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kreymann, G.</creatorcontrib><collection>CrossRef</collection><jtitle>The South African journal of clinical nutrition</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kreymann, G.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Optimal composition of intravenous lipids</atitle><jtitle>The South African journal of clinical nutrition</jtitle><date>2010-01-01</date><risdate>2010</risdate><volume>23</volume><issue>sup1</issue><spage>11</spage><epage>14</epage><pages>11-14</pages><issn>1607-0658</issn><eissn>2221-1268</eissn><abstract>The provision of energy from a lipid source is an essential component of any parenteral nutrition (PN) therapeutic regimen in the appropriate clinical setting. All available sources of intravenous lipid emulsions have a low osmolarity but they strongly differ in their immunologic effects and their effects on oxidative stress, liver injury and mitochondrial function. The ω−9/ω−6 lipid emulsion with its relative immune-neutrality and also the newer fish oil admixtures are lipid emulsions that can be used in most critically ill and non-critically ill patients. Despite extensive research and encouraging progress in the availability of such lipid emulsions, there is still need for a lipid emulsions that could be advantageous in patients with real hyperinflammation.</abstract><pub>Taylor & Francis</pub><doi>10.1080/16070658.2010.11734261</doi><tpages>4</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1607-0658 |
| ispartof | The South African journal of clinical nutrition, 2010-01, Vol.23 (sup1), p.11-14 |
| issn | 1607-0658 2221-1268 |
| language | eng |
| recordid | cdi_crossref_primary_10_1080_16070658_2010_11734261 |
| source | Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; African Journals Online (Open Access); Sabinet African Journals Open Access Collection |
| title | Optimal composition of intravenous lipids |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-05T05%3A21%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref_infor&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Optimal%20composition%20of%20intravenous%20lipids&rft.jtitle=The%20South%20African%20journal%20of%20clinical%20nutrition&rft.au=Kreymann,%20G.&rft.date=2010-01-01&rft.volume=23&rft.issue=sup1&rft.spage=11&rft.epage=14&rft.pages=11-14&rft.issn=1607-0658&rft.eissn=2221-1268&rft_id=info:doi/10.1080/16070658.2010.11734261&rft_dat=%3Ccrossref_infor%3E10_1080_16070658_2010_11734261%3C/crossref_infor%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |